Irving L Weissman Selected Research

Irving L Weissman Research Topics

Disease

67	Neoplasms (Cancer) 01/2022 - 07/2003
8	Leukemia 06/2012 - 02/2003
7	Neoplasm Metastasis (Metastasis) 01/2019 - 02/2011
6	Infections 01/2022 - 12/2002
5	Lymphoma (Lymphomas) 01/2020 - 06/2009
5	Melanoma (Melanoma, Malignant) 01/2020 - 05/2008
5	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 08/2009
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2018 - 09/2010
5	Teratoma (Teratoid Tumor) 01/2017 - 02/2006
4	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2012
4	Atherosclerosis 01/2020 - 01/2009
4	Inflammation (Inflammations) 01/2020 - 02/2011
4	Hypoxia (Hypoxemia) 11/2018 - 02/2014
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2015 - 12/2003
3	Fibrosis (Cirrhosis) 02/2022 - 01/2017
3	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2013 - 07/2003
2	Neuroblastoma 01/2022 - 12/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2017
2	Wounds and Injuries (Trauma) 01/2021 - 10/2017
2	Brain Neoplasms (Brain Tumor) 12/2020 - 01/2017
2	Glioma (Gliomas) 12/2020 - 01/2017
2	Atherosclerotic Plaque (Atheroma) 01/2020 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 04/2009
2	Body Weight (Weight, Body) 11/2018 - 01/2018
2	Medulloblastoma 10/2018 - 01/2017
2	Carcinogenesis 01/2018 - 03/2005
2	Hypertrophy 01/2018 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 01/2017
2	Glioblastoma (Glioblastoma Multiforme) 02/2017 - 01/2017
2	Disease Progression 01/2016 - 02/2013
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2013 - 02/2013
2	Circulating Neoplastic Cells 01/2012 - 11/2011
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 11/2011 - 10/2009
2	Blast Crisis (Blast Phase) 03/2009 - 08/2004
1	Cicatrix (Scar) 02/2022
1	Breakthrough Infections 01/2022
1	COVID-19 01/2022
1	Cytokine Release Syndrome 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Lewis Lung Carcinoma 01/2021

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2003
20	AntibodiesIBA 01/2022 - 09/2010
19	Monoclonal AntibodiesIBA 01/2022 - 09/2010
8	AntigensIBA 01/2021 - 07/2010
7	Transcription Factors (Transcription Factor)IBA 11/2020 - 05/2007
6	CytokinesIBA 01/2022 - 04/2015
6	LigandsIBA 01/2022 - 01/2009
5	magrolimabIBA 01/2021 - 01/2015
4	CalreticulinIBA 01/2022 - 12/2010
4	beta CateninIBA 08/2009 - 08/2004
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021 - 04/2016
3	Rituximab (Mabthera)FDA Link 01/2021 - 09/2010
3	Complement System Proteins (Complement)IBA 01/2020 - 12/2013
3	ChemokinesIBA 01/2020 - 01/2009
3	Immune Checkpoint InhibitorsIBA 11/2018 - 11/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 05/2008
3	Imatinib Mesylate (Gleevec)FDA Link 06/2013 - 08/2004
3	Phosphotransferases (Kinase)IBA 02/2011 - 03/2009
2	HydrogelsIBA 02/2022 - 10/2017
2	Messenger RNA (mRNA)IBA 01/2022 - 04/2012
2	Immunoglobulin G (IgG)IBA 01/2022 - 02/2017
2	Peptides (Polypeptides)IBA 01/2021 - 05/2008
2	Epidermal Growth Factor (EGF)IBA 01/2021 - 12/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 04/2009
2	EnzymesIBA 01/2021 - 09/2009
2	Fc Receptors (Fc Receptor)IBA 01/2020 - 09/2010
2	Oxygen (Dioxygen)IBA 01/2018 - 04/2009
2	Adapalene (Differin)FDA LinkGeneric 01/2016 - 07/2010
2	MicroRNAs (MicroRNA)IBA 10/2015 - 03/2010
2	matrigelIBA 02/2014 - 05/2008
2	Biological ProductsIBA 10/2007 - 12/2006
2	Ganciclovir (Cytovene)FDA LinkGeneric 01/2007 - 02/2006
1	PolymersIBA 02/2022
1	AlkaliesIBA 02/2022
1	COVID-19 VaccinesIBA 01/2022
1	Secretory ComponentIBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	VaccinesIBA 01/2022
1	Myosin Light Chains (Myosin Essential Light Chain)IBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	EpitopesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	ML 7IBA 01/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	epidermal growth factor receptor VIIIIBA 12/2020
1	Semaphorin-3AIBA 12/2020

Therapy/Procedure

31	Therapeutics 02/2022 - 04/2006
21	Immunotherapy 01/2020 - 04/2012
11	Transplantation 01/2017 - 12/2002
5	Cell Transplantation 10/2016 - 07/2003
4	Drug Therapy (Chemotherapy) 01/2021 - 06/2007
4	Heterologous Transplantation (Xenotransplantation) 01/2014 - 01/2012
3	Radiotherapy 01/2017 - 01/2005
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2016 - 08/2008
2	Ligation 01/2022 - 06/2014
2	Hepatectomy 01/2018 - 01/2017
2	Surgical Amputation (Amputations) 01/2018 - 01/2017
2	Hematopoietic Stem Cell Transplantation 07/2003 - 12/2002
1	Transjugular Intrahepatic Portasystemic Shunt 09/2021